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The NF-κB1 is a key regulator of acute but not chronic
renal injury
Amy Fearn1, Gerhard R Situmorang1,2, Christopher Fox1, Fiona Oakley1, Rachel Howarth1, Caroline L Wilson1, Agklinta Kiosia1,
Michael G Robson3, Derek A Mann1, Anna Moles1,4 and Neil S Sheerin*,1,4
The NF-κB family of transcription factors is important for many cellular functions, in particular initiation and propagation of
inflammatory and immune responses. However, recent data has suggested that different subunits of the NF-κB family can
suppress the inflammatory response. NF-κB1, from the locus nfκb1, can inhibit transcription, acting as a brake to the recognised
pro-inflammatory activity of other NF-κB subunits. We tested the function of NF-κB1 in an acute (nephrotoxic serum (NTS)
nephritis) and a chronic (unilateral ureteric obstruction (UUO)) model of renal injury using NF-κB1 (nfκb1− /−) knockout mice.
Deficiency in NF-κB1 increased the severity of glomerular injury in NTS-induced nephritis and was associated with greater
proteinuria and persistent pro-inflammatory gene expression. Induction of disease in bone marrow chimeric mice demonstrated
that the absence of NF-κB1 in either bone marrow or glomerular cells increased the severity of injury. Early after UUO (day 3) there
was more severe histological injury in the nfκb1− /−mice but by day 10, disease severity was equivalent in wild type and nfκb1− /−
mice. In conclusion, NF-κB1 modifies acute inflammatory renal injury but does not influence chronic fibrotic injury.
Cell Death and Disease (2017) 8, e2883; doi:10.1038/cddis.2017.233; published online 15 June 2017
Glomerulonephritis (GN) is one of the leading causes of end
stage renal disease (ESRD) accounting for up to 40% of
ESRD in some countries.1 Many types of glomerular disease
are immune-mediated, characterised by the presence of
circulating autoantibodies and/or glomerular immune complex
deposition2 (anti-glomerular basement membrane disease,
membranous nephropathy, lupus nephritis, and anti-neutrophil
cytoplasmic antibody-associated vasculitis) and their mea-
surement is important for diagnosis. In addition to antibodies,
lymphocytes, macrophages and fluid phase mediators of
inflammation, in particular complement, have been implicated
in the development of glomerular injury. The autoimmune
response leads to glomerular inflammation and to a progres-
sive decline in renal function due to glomerulosclerosis and
tubulointerstitial fibrosis. Activated pro-inflammatory and pro-
fibrotic mediators induce and sustain the pathophysiological
events occurring within the affected kidney, including; renal
vasoconstriction, immune cell infiltration, interstitial cell pro-
liferation, accumulation of extracellular matrix proteins and
eventually glomerular sclerosis and tubular atrophy. For most
glomerulonephritides the trigger that initiates disease is
unknown and the underlying disease mechanisms poorly
understood. Current treatments for GN are nonspecific, toxic
and of variable efficacy. Therefore better understanding of the
biological drivers of GN is urgently needed in order to design
more specific therapies.
NF-κB1 (p50) is one of the five members (RelA, RelB, c-Rel,
NF-κB1 and NF-κB2) of the NF-κB transcription factor family.
NF-κB members can potentially generate fifteen NF-κB homo-
or heterodimers which will bind to κB sequence elements
present in the promoter or enhancer regions of target genes,
regulating multiple pathways involved in cell survival and
death, organ development, inflammation and immunological
responses.3 All NF-κB members share a Rel homology
domain responsible for DNA-binding and dimerisation how-
ever, only three of them (RelA, RelB, c-Rel) have a C-terminal
transactivation domain which is required to modulate gene
transcription. NF-κB1 (p50, generated from the precursor
p105) and NF-κB2 (p52, generated from the precursor p100)
lack this domain and acquire transactivation function by either
forming Rel/p50 and Rel/p52 heterodimers or associating with
non-Rel coactivator proteins.4,5 NF-κB1 (p50) and 2 (p52) pro-
teins can also form homodimers which have an important role
as transcriptional repressors, modifying expression of NF-κB
target genes, including those involved in inflammation.6,7
Increasing evidence suggests important roles for NF-κB
proteins in renal disease progression,8 mediating renal
inflammation by promoting gene expression in different cell
types, including renal cells, innate immune cells and
lymphocytes.9 Many reports regarding NF-κB function in vivo
focus on RelA/p50 heterodimers, overlooking the complexity
of this transcription factor family. Due to the potential dual role
of the NF-κB1 in both promoting and repressing inflammation
further studies are needed in order to clarify the role of this
subunit in renal disease pathophysiology.
To characterise the contribution of NF-κB1 in the develop-
ment of immune complex driven kidney disease we used the
nephrotoxic serum (NTS) glomerulonephritis model. In this
manuscript we report that animals deficient in NF-κB1 (p50
and its precursor p105) hadmore severe glomerular injury and
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a persistent inflammatory response following NTS injection. A
shared contribution to this phenotype by both bone marrow-
derived inflammatory cells and resident renal cells was
demonstrated using bone marrow chimeric mice. However,
in contrast to acute inflammatory injury, absence of NF-κB1 did
not alter the progression of chronic injury. Therefore NF-κB1
has an important role driving the early inflammatory response
in infiltrating and resident renal cells during the acute phase of
glomerulonephritis.
Results
NF-κB1 deficiency exacerbates glomerular injury in NTS
nephritis. The NTS nephritis mouse model has many
features which are common to clinical GN. These include,
inflammatory cell influx to the kidney, proteinuria, and
crescentic glomerulonephritis. In this model proteinuria and
transient kidney injury is achieved by the administration of
sheep anti-mouse glomerular basement membrane (GBM)
heterologous antibodies which bind to target antigens in the
recipient glomerulus. WTand nfκb1− /− mice were given NTS
through tail vein injection and kidneys harvested after 2 or
24 h. Neutrophil infiltration was evident 2 h after NTS
injection. No differences in the number of infiltrating
neutrophils (Figure 1a; Supplementary Figures 1A and B)
or macrophages (Figure 1b; Supplementary Figure 1C) per
glomerulus were detected between WT and nfκb1− /− mice.
Of note and consistent with previous reports in this model,
24 h after NTS injection the neutrophil infiltrate had resolved
(Figure 1a).
Glomerular injury and thrombosis was evident in WT and
nfκb1− /− mice after 24 h of NTS injection. Glomerular injury
was significantly worse in nfκb1− /− mice compared with WT
mice. Extensive glomerular thrombosis was only evident in
nfκb1− /− animals (Figure 1c). Therefore, lack of NF-κB1
results in worse and more extensive glomerular injury during
NTS-induced GN.
Proteinuria is increased in mice deficient in NF-κB1
despite equivalent binding of heterologous antibody. To
confirm that the excess glomerular injury observed in the
nfκb1− /− mice (Figure 1c) was not due to a difference in
nephrotoxic antibody binding, the amount of sheep IgG
present in the glomeruli was quantified at 2 and 24 h post-
injection. No significant differences of the mean fluorescence
intensity was detected in the glomeruli of WT and nfκb1− /−
mice at 2 or 24 h indicating no differential binding of the anti-
GBM heterologous antibody (Figure 2a). Complement activa-
tion, as assessed by C3 deposition in the glomeruli, was also
similar in WT and nfκb1− /− mice 2 h after NTS injection
(Figure 2b).
In addition to histological glomerular injury, glomerular
function was assessed by measuring 24 h urine albumin
excretion. NTS injection resulted in functional injury to the
glomerulus as reflected by an increase in urine albumin
excretion in WT and nfκb1− /− mice after NTS challenge
(Figure 2c). The nfκb1− /− mice exhibited significantly higher
urinary albumin excretion than WT.
To determine whether nfκb1− /− mice had an increased
sustained response to injury over time, disease severity was
assessed 7 days after NTS administration. Blood urea
nitrogen analysis showed no differences in kidney function
between WT and nfκb1− /− mice (Supplementary Figure 2A).
In addition no differences were detected in the glomerular
injury score (Supplementary Figure 2B) and macrophage
infiltration (Supplementary Figure 2C) in the glomeruli of WT
and nfκb1− /− mice. Taken together with the histological
changes this result confirms that NF-κB1 is important in
preserving glomerular structure and function during acute
experimental GN.
NF-κB1 deficiency increases pro-inflammatory gene
expression. Disease progression on the NTS-induced
nephritis model can be divided in two distinctive phases.
During the first few days (or the ‘heterologous’ phase) the
damage is dependent upon infiltrating neutrophils, comple-
ment activation and pro-inflammatory cytokines.10
To assess the inflammatory response of both WT and
nfκb1− /− mice we determined the levels of key pro-
inflammatory proteins (TNF-α, IL-6, S100A8 and S100A9)
which are known downstream targets for NF-κB as well as
recognised contributors to GN disease progression.11–13 TNF-
α, S100A8 and S100A9 gene expression in kidney was
upregulated 2 h after NTS challenge in both WTand nfκb1− /−
(Figures 3a,c,d) in comparison with WT saline injected
animals. No difference was seen in IL-6 expression
(Figure 3b). TNF-α levels were significantly higher in
nfκb1− /− versus WT mice 2 h after NTS injection (Figure 3a).
Although the levels of TNF-α, S100A8 and S100A9 expression
in nfκb1− /− mice had fallen by 24 h, they were significantly
higher than in the WT group (Figures 3a,c,d). These data are
consistent with NF-κB being involved in both onset and
resolution of acute inflammation.14
NF-κB1 in both immune and resident renal cells is
involved in the development of injury. NF-kB activation
can have a dual role driving renal disease by regulating
immune cell biological responses as well as modulating the
response of resident renal cells to injury.8 To dissect the
contribution of Nfκb1 to disease development in immune and
resident cells we generated bone marrow chimeric animals.
Recipient mice were irradiated and transplanted with bone
marrow hematopoietic progenitor cells from donor mice
generating four chimeric combination: WT to WT, nfκb1− /−
to nfκb1− /−, nfκb1− /− to WT, WT to nfκb1− /−. Peripheral
blood screening confirmed bone marrow conversion to donor-
type after 6 weeks (Supplementary Figures 3A and B). NTS
nephritis was induced in the four chimeric groups by NTS
injection. Binding of antibody to the GBM was the same
across the different chimeric mice (Supplementary Figure 4).
In agreement with Figures 1c and d, glomerular injury score
was significantly higher in nfκb1− /−→nfκb1− /−, than in
control chimeric WT→WT mice. Mice deficient in NF-κB1 in
either bone marrow-derived cells (nfκb1− /−→WT) or renal
resident cells (WT→nfκb1− /−) developed significantly
greater glomerular injury compared with control chimeric
WT→WT (Figure 4a). This result suggests a role for NF-κB1
in both bone marrow-derived cells and renal resident cells
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during the development of glomerular injury following NTS
injection.
Glomerular function was assessed in chimeric mice by
analysing 24 h urine albumin excretion. The level of albumi-
nuria was higher in nfκb1− /−→nfκb1− /− than in WT→WT
(Figure 4b) consistent with worse glomerular function.
Transplant of nfκb1− /− bone marrow into WT mice
(nfκb1− /−→WT) or WT bone marrow into nfκb1− /− (WT→
nfκb1− /−) led to similar levels of albuminuria as nfκb1− /−
→nfκb1− /−. Therefore glomerular permselectivity is also
dependent on the absence of NF-κB1 in bone marrow-
derived cells and renal resident cells.
Absence of NF-κB1 in either immune or resident renal
cells leads to slower resolution of the acute inflammatory
response to NTS-induced nephritis. Resolution of the
inflammatory response to NTS injection was delayed in mice
deficient in NF-κB1 (Figures 3a–d) which could contribute to
the greater glomerular injury (Figure 1c) and impaired
glomerular function (Figure 2c) present in these animals.
We next analysed the contribution from infiltrating inflamma-
tory cells and resident renal cells to this delayed resolution
phenotype. Gene expression levels of TNF-α, IL-6, S100A8
and S100A9 were analysed in the four different chimeric mice
24 h after NTS injection. As expected nfκb1− /−→nfκb1− /−
mice showed higher levels of TNF-α, IL-6, S100A8 and
S100A9 than WT→WT (Figures 5a–d). Lack of NF-κB1 in
both bone marrow-derived immune cells (nfκb1− /−→WT)
and kidney resident cells (WT→nfκb1− /−) was associated
with higher levels of TNF-α in comparison to chimeric
WT→WT (Figure 5a). Transplant of nfκb1− /− bone marrow
into WT (nfκb1− /−→WT) resulted in expression of IL-6,
S100A8 and S100A9 (Figures 5b–d) close to WT→WT
levels. WT bone marrow transplant into nfκb1− /− showed an
Figure 1 NF-κB1-deficient mice have more severe glomerular injury after NTS-induced glomerulonephritis. Average number of neutrophils (NIMP+) per glomerular cross-
section in WTand nfκb1− /− renal tissues 2 and 24 h post-NTS injection and representative NIMP IHP pictures at 2 h showing neutrophil infiltration (red arrows) in a glomeruli (a).
Average mean fluorescence intensity of F4/80+ staining per glomerular cross-section in WTand nfκb1− /− renal tissues 2 and 24 h post-NTS injection and representative F4/80
IHP pictures at 24 h showing macrophage positive staining in a glomeruli (b). Glomerular injury score in WTand nfκb1− /− mice 24 h post-NTS injection and representative PAS
pictures showing areas of glomerular thrombosis (red arrows) in a glomeruli (c). N= 6, unpaired t-test, *P⩽ 0.05 or **P⩽ 0.01
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intermediate phenotype between nfκb1− /−→nfκb1− /− and
WT→WT. Of note, IL-6 gene expression in non-chimeric
(Figure 3b) and chimeric mice (Figure 5b) after NTS
challenge was different. This could be down to the presence
of resident monocytic cells in the chimeric mice, which will not
be affected by the chimeric switch and could influence tissue
inflammation.
These results indicate that NF-κB1 is responsible for gene
and cell regulation and that both circulating immune cells and
renal resident cells contribute to the delayed resolution
response present in the nfκb1− /− mice.
Increased inflammatory responses in circulating and
resident renal cells deficient in NF-κB1. We next explored
the role of NF-κB1 in circulating and resident renal cells. To
assess the contribution of circulating cells we focused on
bone marrow-derived macrophages and circulating leuko-
cytes which are important effectors of the heterologous phase
of NTS-induced nephritis. Circulating leukocytes fromWTand
nfκb1− /− were exposed to different inflammatory stimuli.
Nfκb1− /− leukocytes had a greater oxidative response to
Escherichia coli, but not fMLP or PMA, compared with WT
(Figures 6a and b). In agreement with the gene expression
levels of the NTS-challenged chimeric mice (Figures 5a–d),
nfκb1− /− bone marrow-derived macrophages stimulated with
LPS showed greater and sustained levels of TNF-α gene
expression (Figure 6c) compared with WT macrophages but
similar levels of S1A008 (Figure 6d).
Mesangial cells have an important role in glomerular
inflammation.15 Mesangial cells were isolated from WT and
nfκb1− /− mice, treated with LPS for 2 and 24 h and gene
expression for TNF-α and S100A8 was evaluated. While WT
Figure 2 NF-κB1-deficient mice have impaired glomerular function after NTS-induced glomerulonephritis despite equivalent heterologous antibody deposition. Mean
fluorescence intensity quantification and representative pictures (a) of anti-GMB antibody binding to glomerular basal membrane of the glomeruli 2 and 24 h post-NTS injection in
WTand nfκb1− /− mice. Average of % C3+ area per glomerular cross-section in WTand nfκb1− /− renal tissues 2 h post-NTS injection and representative pictures showing C3
positive staining in a glomeruli (b). Albumin concentration in the urine collected for 24 h after 2 or 24 h NTS injection (c). N= 6, one way ANOVA, *P⩽ 0.05 or **P⩽ 0.01
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mesangial cells were almost unresponsive to LPS, nfκb1− /−
mesangial cells demonstrated a significant response at 2 and
24 h (Figures 7a–d). Our results confirm circulating and renal
mesangial cells deficient in NF-κB1 generate a greater
inflammatory response than WT cells, pointing towards an
anti-inflammatory role for NF-κB1.
NF-κB1 bone marrow-derived macrophages present an
impaired MAPK phosphorylation response to TNF-α.
NF-κB1 has been implicated in the regulation of MAPK
signalling pathway16,17 which also have an important role
regulating the immune response. Therefore, we next inves-
tigated the activation of MAPK in WT and nfκb1− /− bone
marrow-derived macrophages stimulated with TNF-α.
Nfκb1− /− bone marrow-derived macrophages showed lower
levels of P38 and ERK phosphorylation after TNF-α treatment
(Figure 7e). In agreement, JNK phosphorylation was also
lower in nfκb1− /− bone marrow-derived macrophages than in
WT. Of note, a second phosphorylation wave of P38 and ERK
was observed 2 h after TNF-α stimulation in WT cells. This
was absent in nfκb1− /− bone marrow-derived macrophages
(Figure 7e). Our results demonstrate a defective MAPK
phosphorylation response in nfκb1− /− macrophages.
NF-κB1 deficiency does not increase the severity of
injury after UUO. Our results had clearly demonstrated
NF-κB1 deficiency worsens acute glomerular pathology, we
next assessed whether it had a similar effect on the more
chronic injury associated with ureteric obstruction. To study
the inflammatory and the fibrotic phase of this model we
performed unilateral ureteric obstruction (UUO) in WT and
nfκb1− /− mice and harvested the kidneys at 3 and 10 days.
Figure 3 NF-κB1-deficient mice have increased and sustained inflammatory responses after NTS-induced glomerulonephritis. TNF-α (a), IL-6 (b), S100A8 (c) and S100A9
(d) mRNA expression in kidney from saline and NTS-challenged WT and nfκb1− /− mice at 2 and 24 h. N= 6, repeated series of t-test, *P⩽ 0.05 or **P⩽ 0.01
Figure 4 Glomerular injury is driven by the lack of NF-κB1 in circulating and renal resident cells after NTS-induced glomerulonephritis. Glomerular injury score in chimeric
mice WT→WT, nfκb1− /−→ nfκb1− /−, nfκb1− /−→WTand WT→ nfκb1− /− (a). Albumin concentration in the urine collected for 24 h after 24 h NTS injection (b). N= 7 for
nfκb1− /−→WTand WT→ nfκb1− /−, one way ANOVA, *P⩽ 0.05 or **P⩽ 0.01
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Tubular dilatation and interstitial expansion (Figures 8a and b)
was significantly higher during the inflammatory phase of the
model (3 days post-UUO) in nfκb1− /− mice versus WT.
However, 10 days after UUO tubular dilatation and interstitial
expansion were equivalent in WT and nfκb1− /− mice
(Figures 8c and d). Our results demonstrate that NF-κB1 is
important in the early phases of glomerular and tubular injury
but deficiency does not influence the progression into the
chronic/fibrotic phase.
Discussion
The clinical manifestations of glomerulonephritis (GN) are a
result of acute often persistent inflammation. Research into the
immune and inflammatory basis of glomerulonephritis tend to
focus on the mechanisms that drive glomerular inflammation.
However, there may be pathways that regulate inflammation
and therefore influence the severity of injury. In this manuscript
we describe a key role for NF-κB1, expressed in both resident
and infiltrating cells, in the regulation of glomerular
inflammation.
NF-κB is a family of pleiotropic transcription factors
regulating transcription of hundreds of genes related to
inflammation, immunity, apoptosis, cell proliferation and
differentiation. NF-κB is known to be activated in both patients
with kidney disease (diabetic nephropathy,18 glomerular
disease19) and animal models of renal inflammation and
injury.8 NF-κB is considered to promote inflammation during
renal diseasewith evidence correlating NF-κB activation to the
severity of renal disease.18,20 However, most of the reports are
limited to the function of the NF-κB heterodimer, RelA/p50,
while the function of other NF-κB complexes in renal disease is
still not clear. It has been suggested that the NF-κB1 subunit,
p50, which is encoded by nf-κb1 gene, has a dual role in many
pathological processes promoting inflammation as hetero-
dimer (RelA/p50) or repressing it as homodimer (p50/p50).21
Here we investigate the role of NF-κB1 in NTS-induced GN
mouse model. Our results demonstrate nfκb1− /− mice, which
are deficient in p50 subunit and its precursor p105, had
increased glomerular injury (Figures 1c and 2c) 24 h after NTS
injection compared with WT mice. Similar levels of infiltrating
neutrophils (Figure 1a; Supplementary Figures 1A,B), macro-
phages (Figure 1b; Supplementary Figure 1C) and C3
deposition (Figure 2b) were seen at the site of injury
suggesting an equivalent immediate response to heterolo-
gous antibody, in WT and nfκb1− /− mice but the subsequent
injury that developed at 24 h was more severe. Our results are
consistent with the proposed protective role of p50 in rat
models of ischaemia reperfusion22 and anti-Thy1
glomerulonephritis.23 Prolonged NTS challenge (7 days) did
not demonstrate delayed injury resolution in nfκb1− /− mice
(Supplementary Figures 2A–C), demonstrating an important
function for NF-κB1 during acute but not chronic
experimental GN.
NF-κB is involved in both the initiation and resolution of the
acute inflammatory response14 having opposite roles at
different stages of inflammation. During the initiation NF-κB
stimulates the synthesis of inflammatory mediators such as
TNF-α, angiotensin II and monocyte chemoattractant
protein-1 (MCP-1). In contrast during resolution, NF-κB
down-regulates inflammatory genes, up-regulates anti-inflam-
matory genes and induces apoptosis of leukocytes. Our
assessment of inflammatory mediators in WT and nfκb1− /−
mice after 2 and 24 h of NTS challenge demonstrated an
Figure 5 NF-κB1 deficiency in both circulating and resident kidney cells regulates cytokine gene expression. TNF-α (a), IL-6 (b), S100A8 (c) and S100A9 (d) mRNA
expression in kidney from 24 h NTS-challenged WT→WT, nfκb1− /−→ nfκb1− /−, nfκb1− /−→WT and WT→ nfκb1− /− chimeric mice. N= 7 for nfκb1− /−→WT and
WT→ nfκb1− /−, one way ANOVA, *P⩽ 0.05 or **P⩽ 0.01
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increased and sustained inflammatory response (Figures
3a–d) in nfκb1− /−mice. Themore severe phenotype observed
in the nfκb1− /− mice could be a result of the absence of
p50/p50 homodimers, which are thought to act as repressors
for the NF-κB mediated inflammatory gene induction during
experimental renal injury.22
During renal disease NF-κB controls injury by modulating
the response of infiltrating immune cells and kidney resident
cells. To analyse the contribution of each of these cell typeswe
generated bone marrow chimeras. WT mice receiving WT
bone marrow had the least severe disease. The absence of
NF-kB1 in either infiltrating bone marrow-derived cells or
resident renal cells resulted in an increase in disease severity
(Figures 4a and b). This is consistent with the hypothesis that
NF-kB1 has regulatory functions in both resident and
infiltrating cells.
Evidence for the regulatory function of NF-kB1 in both
resident and infiltrating cells was obtained using isolated bone
marrow-derived macrophages and renal mesangial cells.
Macrophages from nfκb1− /− mice had greater TNF-α expres-
sion compared with WT macrophages after LPS challenge
(Figure 6c), whilst mesangial cells had increased expression
of both TNF-α and S100A8 (Figures 7a–d). With the recent
report of a key role for the proteins S100A8 and S100A913 in
glomerular inflammation and the known function of TNF-α,
NF-kB1may regulatemultiple pathways involved in glomerular
inflammation.
To have its essential role controlling inflammation, NF-kB
requires the assistance of other transcription factors, such as
members of the activator protein (AP)-1 family, which are
dependent on mitogen activated protein kinase (MAPK)
signalling pathways.24 Therefore we next analysed the MAPK
signalling pathways in bone marrow-derived macrophages
after TNF-α treatment. In agreement with previous
reports,16,25 Nfκb1− /− bone marrow-derived macrophages
showed impaired MAPK phosphorylation in comparison with
WT (Figure 7e). NF-kB1 can regulate TPL-2 activity, which is
the upstream kinase for the activation of theMAPKs.26 Further
Figure 6 Inflammatory responses from WT and NF-kB1-deficient leukocytes and macrophages. Percentage of WT or nfκb1− /− circulating leukocytes producing reactive
oxidants (conversion of DHR123 to R123) after stimulation with E. coli, fMLP and PMA (a). Enzymatic activity per cell as expressed by R123 signal in circulating leukocytes of WT
or nfκb1− /− after stimulation with E. coli, fMLP and PMA (b). TNF-α (c) and S100A8 (d) mRNA expression in bone marrow-derived macrophages from WTor nfκb1− /− treated
with 100 ng/ml of LPS for 2, 4, 6 and 24 h. N= 3, unpaired t-test (a,b), one way ANOVA (c,d), *P⩽ 0.05 or **P⩽ 0.01
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investigation will need to be done to fully understand the
relative contribution of alteredNF-kB function and the impaired
activation of the MAPKs to the altered immune responses
present in the nfκb1− /− mice.
In addition to the phenotype in bone marrow-derived
macrophages and renal mesangial cells, isolated leukocytes
from nfκb1− /− mice showed greater oxidative response than
WT (Figures 6a and b), therefore infiltration of nfκb1− /−
leukocytes in the site of injury have the potential to cause
greater damage. As reported previously our data suggests
that NF-kB1 controls cell responses in multiple cell types.
Previous reports have also described not only a cell
dependent but also a time-dependent role for NF-kB1 during
acute renal injury. Absence of NF-kB1 during the first 24 h of
sepsis-induced acute kidney injury reduced renal
inflammation,27 however the lack of NF-kB1 at 48 h resulted
in higher mortality and prolonged renal inflammation.23 To
analyse the role of p50 in a more chronic injury we used the
tubular injury model of unilateral ureteric obstruction or UUO.
NF-kB1 absence led to increased tubular dilatation and
interstitial expansion after UUOduring the inflammatory phase
of the injury, 3 days (Figures 8a and b). However, no
differences where observed in the chronic/fibrotic phase,
10 days (Figures 8c and d). Our results demonstrate a critical
protective role for NF-kB1 during the onset of acute renal injury
but not the chronic phase.
Figure 7 Renal resident mesanglial cells and bone marrow-derived macrophages deficient in NF-κB1 present increased inflammatory responses and impaired MAPK
activation respectively. TNF-α (a,b) and S100A8 (c,d) mRNA expression in kidney mesangial cells from WT or nfκb1− /− after 2 h or 24 h stimulation with LPS. p-P38, P38,
p-ERK, ERK, p-JNK, JNK and GAPDH protein expression in bone marrow-derived macrophages from WTor nfκb1− /− treated with 50 ng/ml of TNF-α for 10, 30, 60 and 120 min
(e). N= 3, one way ANOVA, *P⩽ 0.05 or **P⩽ 0.01
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The pro-inflammatory activity of NF-κB has made it an
attractive option for drug targeting. Therapeutic and pre-clinic
efficacy has been shown in models of rheumatoid arthritis and
inflammatory bowel disease.28 However, according to our res-
ults, future therapeutic approaches targeting NF-κB will need
to carefully consider the protective functions of the NF-κB
subunit p50 (NF-kB1) during the onset of acute renal injury.
Materials and Methods
Animal models of renal disease. All animals were used in accordance
with UK Home Office regulations and the Animals (Scientific Procedures) Act 1986.
Nfkb1− /− mice29 were bred as homozygous lines and compared with C57BL/6 WT
mice. NTS nephritis was induced in WT, nfκb1− /− or chimeric mice by tail vein
injection of 200 μl of NTS containing 0.5 ng/μl LPS.30 Controls were tail vein-
injected with equivalent volume of saline. Kidneys were harvested 2 h, 24 h or
7 days after injection. Mice were housed in metabolic cages for 24 h pre and post-
NTS injection. Unilateral ureteric obstruction (UUO) was performed in WT and
nfκb1− /− mice as described previously.31,32 Kidneys were harvested at 3 and
10 days post-UUO. A minimum of 6 animals were used in each experimental group.
Generation of bone marrow chimeras. Bone marrow cells were
harvested from the femurs of donor mice using standard techniques. Recipient
mice were irradiated (10 Gy) and after 4 h injected with 107 donor bone marrow
cells. After 6 weeks conversion was assessed by PCR on genomic DNA isolated
from blood prior to induction of NTS nephritis for 24 h. After mice were killed bone
marrow was harvested to assess the presence of NF-κB p50 protein in cell lysates
by western blot (Supplementary Figure 3A and B).
Glomerular injury score. Two micron sections of formalin fixed, wax
embedded kidneys were stained with Periodic Acid Schiff (PAS) following standard
procedure. Infiltrating neutrophils in the glomeruli were identified by their typical
nuclear morphology.33 Glomerular thrombosis was blindly scored as ‘0’ (no injury),
‘1’ (o25% injury), ‘2’ (25–50% injury), ‘3’ (50–75% injury) and ‘4’ (75–100%
injury).34 At least 15 glomeruli (2 h NTS) or 30 glomeruli (24 h NTS) were counted
per section.
Biochemical analysis. Blood urea nitrogen (BUN) was performed in the
Clinical Biochemistry department, Newcastle upon Tyne Hospitals NHS
Foundation Trust.
Measurement of urinary albumin concentration. Urine albumin
concentration was measured by radial immunodiffusion in 1.2% agarose gels
containing 150 μl of rabbit anti-mouse albumin antibody (Abcam, Cambridge, UK)
per 10 ml of gel. The diameter of precipitation rings was measured using UTHSCSA
Image Tool 3.0 computer software (University of Texas Health Science Centre, San
Antonio) and urinary albumin concentrations calculated from known standards.
Interstitial expansion and tubular dilation analysis. For the UUO
kidneys analysis of interstitial expansion and tubular dilatation was performed by
superimposing a 10 × 10 grid over each of 20 non-overlapping 250 × cortical
images for each section. Intersections overlaying either interstitial space or tubular
luminae were counted and expressed as a percentage of the total area containing
81 grid intersections.
Immunohistochemical staining and analysis. Immunohistochemistry
was performed in 4 μm formalin-fixed kidney slides. Sections were deparaffinised
and endogenous peroxidase was blocked with 2% hydrogen peroxide/methanol.
Pronase, Proteinase K and heat mediated sodium citrate antigen retrieval was
performed for NIMP, F4/80 and C3 staining respectively. Afterwards endogenous
avidin and biotin were blocked. Blocking solution and primary antibody was added
overnight (NIMP, F4/80 and C3 from Abcam). After the addition of secondary
biotinylated antibody and ABC, sections were developed with DAB, counterstain with
Mayer’s haematoxylin and mounted with Pertex. NIMP+ cells were manually
counted in at least 15 random glomeruli per section. F4/80 and C3 morphometric
image analysis was performed at 400 × using Nikon Eclipse Upright microscope
and NIS-Elements BR Analysis software from Nikon. At least 10 random glomeruli
were analysed per kidney and data is expressed as percentage of positive staining
per glomeruli.
Figure 8 NF-κB1-deficient mice show greater tubular dilation and interstitial expansion during the inflammatory phase of UUO. Percentage score of tubular dilatation and
interstitial expansion in kidney tissue from WT and nfκb1− /− controls, 3 days (a,b) or 10 days (c,d) UUO. N= 6, one way ANOVA, *P⩽ 0.05 or **P⩽ 0.01
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Immunofluorescent staining. Kidney sections were deparaffinized and
hydrated. Proteinase K antigen retrieval was performed. Blocking solution was
added followed by F4/80 antibody (Abcam) overnight. After washing, secondary
Alexa Fluor 568 was added and slides were mounted with Prolong mounting
medium. Image analysis was performed with a Zeiss Axioimager Apotome
microscope and Image J Software (National Institute of Health, USA). Data is
expressed as average mean fluorescence intensity in the glomeruli.
NTS glomerular binding assessment. Glomerular binding of NTS was
visualised using FITC conjugated donkey anti-sheep antibody on unfixed kidney
cryosections blocked with 5% horse serum. Slides were imaged using a Leica LMD
microscope. Fluorescence intensity was analysed using Image J software.
Mesangial cell isolation and culture. Mesangial cells were isolated as
described before.35 Briefly, WT or nfkb1− /− kidney cortex was mince and passed
through 100 μm followed by 40 μm cell strainers. The material that would not pass
through the strainer was collected, centrifuged and the pellet was digested with
collagenase IV for 10 min at 37 °C. Glomeruli cell outgrowths were passaged four
times before obtaining mesangial cells. Mesangial cells were culture in RPMI 1640,
supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin and 1%
insulin, transferrin, selenium and maintained at 37 °C at an atmosphere of 5% CO2.
Bone marrow-derived macrophage isolation and culture. Bone
marrow cells were isolated from femurs of WT or nfkb1− /− mice and differentiated
into macrophages as described previously.21 Cells were serum starved before
treating them with 100 ng/ml of LPS for 2, 4, 6 and 24 h or 50 ng/ml of TNF-α for
10, 30, 60 and 120 min.
Measurement of oxidative burst. The oxidative burst in leukocytes was
measured in heparinized whole blood from WT and nfkb1− /− mice using
Phagoburst kit (Glicotope Biotechnology) according to manufacturer’s instructions.
Using flow cytometry this kit allows the detection of percentage of phagocytic cells
which produce reactive oxidants (conversion of DHR123 to R123) and their
enzymatic activity (amount of R123 per cell) against several stimuli opsonized
bacteria (E. coli), Phorbol 12-myristate 13-acetate (PMA) and N-Formyl-Met-Leu-
Phe (fMLP).
Analysis of gene expression. Total RNA was isolated from homogenised
renal cortex by standard chloroform extraction followed by isopropanol precipitation.
cDNA was synthesised from 250 ng of total RNA. Real time PCR was performed
with SYBR Green JumpStart ready mix according to manufacturer’s instructions.
Data was calculated using ΔΔCt and GAPDH was used as a housekeeping gene.
Data is plotted against WT control group. Primer sequences used are listed in the
Supplementary Table 1.
Statistical analysis. Results are expressed as mean± S.E.M. unless
otherwise stated in the figure legend. All P values were calculated using one
way ANOVA followed by Bonferroni's test or two-tailed unpaired student’s t-test.
*P⩽ 0.05 or **P⩽ 0.01 was considered statistically significant.
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